Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0358420090520040400
Korean Journal of Obstetrics and Gynecology
2009 Volume.52 No. 4 p.400 ~ p.406
Comparison of plasma Lipid and Lipoprotein concentrations in normal and intrauterine growth restriction pregnancies
Bae Jin-Gon

Park Joon-Cheol
Rhee Jeong-Ho
Kim Jong-In
Abstract
Objective: The effects of fetal growth of lipid metabolism in pregnancy are not well understood at present. The aim of this study was to perform a cross sectional study of lipid and lipidprotein concentrations in the 3rd trimester, from normal pregnancies and those complicated by intrauterine growth restriction pregnancies (IUGR) without preeclampsia.

Methods: Fasting blood samples for lipid and lipidprotein fractions were taken 3rd trimester. from fourty two women with IUGR; fourty five women with uncomplicated pregnancies matched as a group for age, parity, gestational age and fetal body weight.

Results: Total cholesterol (6.74¡¾1.14 mmol/L vs 4.23¡¾1.03 mmol/L, P<0.01), triglyceride 2.10¡¾0.95 mmol/L vs 2.42¡¾0.73 mmol/L. P<0.05) and LDL (3.41¡¾0.83 mmol/L vs 4.23¡¾1.07 mmol/L, P<0.01) concentrations were significantly lower in the IUGR group than in normal group. Free fatty acid (0.8¡¾0.21 mmol/L vs 0.5¡¾0.01 mmol/L, P<0.01) concentration, ApoB/ApoA ratio (0.86 ¡¾0.42 vs 0.77¡¾0.47, P<0.01). HDL/ApoA (0.87¡¾0.1 vs 0.72¡¾0.05, P<0.05) ratio were significantly higher in the IUGR group than in normal group. There were no difference in other lipids.

Conclusion: The results of this study suggest that LDL levels, which normally increase in uncomplicated pregnancies, fail to rise appropriately in pregnancies complicated by IUGR and may play a role in the pathogenesis of fetal growth restriction. Change in ApoA and increased ApoB/ApoA ratio may be used in identifying mothers with, or at risk of, a pregnancy complicated by IUGR.
KEYWORD
Lipid and Lipoprotein concentrations, Intrauterine growth restriction pregnancy
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø